CompanyNasdaqGarden City, NY
Beyond Air, Inc
Beyond Air develops nitric oxide-based therapies for respiratory illnesses, neurological disorders, and solid tumors.
DEF 14AOct 30Latest SEC filing
Form DOct 11$21M sold
October 2026
Sign inSign inBeyond Air develops nitric oxide-based therapies for respiratory illnesses, neurological disorders, and solid tumors.